[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:spinal-malignancy":3},{"name":4,"total":5,"trials":6,"biomarkers":15,"states":16},"Spinal Malignancy",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07732413","Trial of NLG802 Indoximod Prodrug Plus Temozolomide for Patients With Progressive Pediatric Brain Cancer",[11],"Phase 1","NOT_YET_RECRUITING","2026-08-03T01:02:43.946935Z","2026-07-30T01:46:14.454333Z",[],[]]